Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "dosing"
Home
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood. Insulin functions like a key, unlocking muscle and...
09/12/2026, 04:20 ET
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C (compound name: OLX72021), an...
08/06/2026, 04:40 ET
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
07/12/2026, 01:39 ET
When Supplements Turn Toxic: The Hidden Risks of Over-Dosing on Calcium and Vitamin D
While nutrients found in natural foods rarely cause significant side effects even when consumed in large amounts,...
03/09/2026, 08:10 ET
Experimental Cancer Drug ACR-2316 Triggers Complete Remission in Advanced Lung Cancer Patient
An advanced lung cancer patient who had previously undergone multiple rounds of systemic therapy achieved a "complete...
11/11/2026, 01:01 ET
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year
The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
10/22/2026, 04:36 ET
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial
Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its...
10/20/2026, 09:25 ET
Blood Sugar Control Improves After 65: Why Age Alone Should Not Dictate Type 1 Diabetes Care
Type 1 and type 2 diabetes stem from fundamentally different underlying etiologies. In type 1 diabetes, an autoimmune...
10/20/2026, 04:08 ET
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval
GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...
09/27/2026, 10:22 ET
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...
09/23/2026, 22:29 ET
1
2
3
Next